The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...

Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...

A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...